Monday, August 3, 2015

Want to work in pharma? Learn another language - or three

Bloomberg News reports that GlaxoSmithKline is hiring more Chinese employees after it was accused by prosecutors in China of using illegal tactics to sell medicine.

Want to work in pharma? Learn another language - or three

0 comments

Foreign language teachers will be happy to learn that a European pharmaceutical industry executive told Bloomberg News that drugmakers are reacting to the GlaxoSmithKline scandal in China by hiring more Chinese-speaking personnel. A link to the story is here.

Bloomberg reported that Chinese police and prosecutors are looking into whether now-former GSK British national Mark Reilly helped set up and expand sales departments that offered bribes to doctors in return for prescribing drugs. GSK, which has operations in and around Philadelphia, is based in London and also faces a U.K. criminal probe. GSK has said it is cooperating with authorities in those countries.

“Some companies are having more Chinese people in key positions,” said Richard Bergstroem, director general of the Brussels-based European Federation of Pharmaceutical Industries and Associations, according to Bloomberg. “In order to do audits further down in the organization, and in order to understand what’s going on, they need people on the ground. Preferably you have someone who speaks the local language.”

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Also on Philly.com:
letter icon Newsletter